GSK a "leaner beast" post-demerger despite first quarter sales slip
(Alliance News) - Derren Nathan, head of equity research at Hargreaves Lansdown, said that GSK PLC got off to a "healthy start" to 2023, despite the pharmaceutical firm reporting a slip in first quarter sales. Read More